Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA ...

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...

Spring’s warmer weather lures people outdoors – and into possible contact with ticks that spread Lyme disease. Already, the ...

Reports Phase 1 Data And Plans Phase 2 Study For Lyme Disease Prevention Candidate. Tonix Pharmaceuticals (NASDAQ: TNXP) announced the presentation of Phase 1 data and plans for an adaptive Phase 2 ...

By the time April’s first warm weekends drew hikers into the woods across the Northeast, emergency rooms were already seeing ...

The researchers found that, in early Lyme disease presentation, there was a higher occurrence of heart palpitations, vomiting, and photophobia among women, while sleep difficulty was greater among men ...

For patients with early infection with Lyme disease (LD), standard and modified two-tiered testing (STTT and MTTT) diagnostic ...

Ali Moresco said she had classic cold and flu symptoms, which led to a two-year delay in diagnosis and permanent bodily ...

Spring is nearly here. And with it, comes tick season. “They emerge from the soil and are actually quite ravenous,” Dr. Ben Clarke shared. The immunologist and professor of biomedical sciences is ...

In a new Johns Hopkins Medicine study, researchers found that male and female patients with early Lyme disease present with different signs of the disease in the symptoms they report, their physical ...